Research

/Research

New Study Outlines Novel Approach to Starving Tumors in Sarcomas

A recent study from Washington University School of Medicine in St. Louis outlines a novel approach to starving tumor cells that is based on a vulnerable point in cancer cell metabolism. The study was [...]

By |2018-10-30T09:23:11-04:00February 13th, 2017|News, Research|

Population-Based Study of Adolescent and Young Adult GIST Patients

Jason Sicklick, M.D Recent findings from a population-based retrospective cohort study at the at Moores Cancer Center at UC San Diego Health, led by senior author, Jason Sicklick, M.D., indicate that small [...]

By |2018-10-30T09:23:26-04:00January 25th, 2017|News, Research|

Study Highlights Role of ABL1 in GIST Treated with Imatinib

A recent study published in Oncotarget, discussed the potential role of the kinase, ABL1 as a potential impediment to anti-tumor processes in GIST treated with imatinib mesylate. The Life Raft Group’s Research Team member, [...]

By |2018-10-30T09:23:31-04:00January 19th, 2017|News, Research|

NIH Pediatric and Wildtype GIST Clinic Report: Surgical Management

A recent report from the National Institutes of Health Pediatric and Wildtype GIST Clinic, published in the Journal of Clinical Oncology suggests that surgical resection for wildtype GIST should be restricted to the initial [...]

By |2018-10-30T09:25:10-04:00January 10th, 2017|News, Research|

Important Research Study Holds Hope for “Quadruple Wildtype” GIST Patients

A recent study published in the Journal of Translational Medicine, presents important research findings for the 10-15% of GIST patients who lack mutations in KIT, PDGFRA, SDHX or RAS pathway indicators, the primary oncogenic [...]

By |2018-10-30T09:25:15-04:00January 6th, 2017|News, Research|

Loxo Oncology Announces Plans for LOXO-101

In a recent press release, Loxo Oncology announced an update on the status of their TRK (tropomyosin receptor kinase) inhibitor drug, larotrectinib (LOXO-101). Larotrectinib targets the NTRK genes, which encode for the TRK kinases. [...]

By |2018-10-30T09:25:21-04:00December 22nd, 2016|Clinical Trials, News, Research|

7th Annual GIST Group Switzerland Prize Awarded to Professor Abbas Agaimy

Left to Right: Martin Wettstein, Dr. Michael Montemurro, Helga Meier Schnorf, Prof. Abbas Agaimy, Prof. Richard Herrmann GIST Group Switzerland, the support group for patients with gastrointestinal stromal tumor (GIST), has awarded [...]

By |2018-10-30T09:26:20-04:00December 19th, 2016|Global, News, Research|

CTOS Provides International Networking Opportunities

Executive Director Norman Scherzer traveled to Lisbon, Portugal in November to attend the 21st annual meeting of the Connective Tissue Oncology Society (CTOS). CTOS is an annual conference which has grown since its inception [...]

By |2018-10-30T09:29:09-04:00November 28th, 2016|Events, Newsletter, Research|

Recent Posts

Upcoming Events

  1. Kathy Sarmiento Medicare 101 Webcast

    LRG Webcast Series: Medicare 101

    September 9 @ 12:00 PM - 1:00 PM
  2. GDOL Ottawa logo

    GIST Day of Learning – Ottawa

    September 28 @ 9:00 AM - 4:30 PM